Organigram Holdings Inc. Capex/Depreciation

Capex/Depreciation of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending February 28, 2022 was -1.43 (a 21.02% increase compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation increased by 170.6%
  • Annual Capex/Depreciation for 2021 was -0.39 (a -90.78% decrease from previous year)
  • Annual Capex/Depreciation for 2020 was -4.27 (a -65.61% decrease from previous year)
  • Annual Capex/Depreciation for 2019 was -12.41 (a -23.77% decrease from previous year)
  • Twelve month Capex/Depreciation ending February 28, 2022 was -0.74 (a 34.93% increase compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by -1020.67% year-over-year
Trailing Capex/Depreciation for the last four month:
28 Feb '22 30 Nov '21 31 Aug '21 31 May '21
-0.74 -0.55 -0.39 0.08
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of Organigram Holdings Inc.

Most recent Capex/Depreciationof OGI including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of Organigram Holdings Inc.

Organigram Holdings Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -1.43
2021 -1.18 -0.37 -0.53 -0.36 -0.39
2020 -0.35 1.54 -4.58 -7.95 -4.27
2019 -9.53 -10.26 -12.39 -15.71 -12.41
2018 -12.97 -5.99 -16.28
2017 0.0
2016 0.0

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic